【レポートの概要(一部)】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 15
2 Introduction 16
2.1 Cardiac Assist Devices Overview 16
3 Products under Development 18
3.1 Cardiac Assist Devices – Pipeline Products by Stage of Development 18
3.2 Cardiac Assist Devices – Pipeline Products by Segment 19
3.3 Cardiac Assist Devices – Pipeline Products by Territory 20
3.4 Cardiac Assist Devices – Pipeline Products by Regulatory Path 21
3.5 Cardiac Assist Devices – Pipeline Products by Estimated Approval Date 22
3.6 Cardiac Assist Devices – Ongoing Clinical Trials 23
4 Cardiac Assist Devices – Pipeline Products under Development by Companies 24
4.1 Cardiac Assist Devices Companies – Pipeline Products by Stage of Development 24
4.2 Cardiac Assist Devices – Pipeline Products by Stage of Development 27
5 Cardiac Assist Devices Companies and Product Overview 31
5.1 Abiomed, Inc. Company Overview 31
5.1.1 Abiomed, Inc. Pipeline Products & Ongoing Clinical Trials Overview 31
5.2 Acorn Cardiovascular, Inc. Company Overview 37
5.2.1 Acorn Cardiovascular, Inc. Pipeline Products & Ongoing Clinical Trials Overview 37
5.3 Arrow International Cr, A.S. Company Overview 40
5.3.1 Arrow International Cr, A.S. Pipeline Products & Ongoing Clinical Trials Overview 40
5.4 Biophan Technologies, Inc. Company Overview 41
5.4.1 Biophan Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 41
5.5 BioQ Devices Pty Ltd Company Overview 43
5.5.1 BioQ Devices Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 43
5.6 BioVentrix, Inc. Company Overview 44
5.6.1 BioVentrix, Inc. Pipeline Products & Ongoing Clinical Trials Overview 44
5.7 BiVacor Pty Ltd Company Overview 48
5.7.1 BiVacor Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 48
5.8 Braile Biomedica Ltda. Company Overview 49
5.8.1 Braile Biomedica Ltda. Pipeline Products & Ongoing Clinical Trials Overview 49
5.9 Calon Cardio-Technology Ltd Company Overview 50
5.9.1 Calon Cardio-Technology Ltd Pipeline Products & Ongoing Clinical Trials Overview 50
5.10 Cardiac Power Inc. Company Overview 53
5.10.1 Cardiac Power Inc. Pipeline Products & Ongoing Clinical Trials Overview 53
5.11 CardiacAssist, Inc. Company Overview 54
5.11.1 CardiacAssist, Inc. Pipeline Products & Ongoing Clinical Trials Overview 54
5.12 Cardiak Ltd. Company Overview 57
5.12.1 Cardiak Ltd. Pipeline Products & Ongoing Clinical Trials Overview 57
5.13 CARDIAnove Company Overview 58
5.13.1 CARDIAnove Pipeline Products & Ongoing Clinical Trials Overview 58
5.14 Cardio Vox, Inc. Company Overview 59
5.14.1 Cardio Vox, Inc. Pipeline Products & Ongoing Clinical Trials Overview 59
5.15 CardioBridge GmbH Company Overview 60
5.15.1 CardioBridge GmbH Pipeline Products & Ongoing Clinical Trials Overview 60
5.16 CardioKinetix, Inc. Company Overview 63
5.16.1 CardioKinetix, Inc. Pipeline Products & Ongoing Clinical Trials Overview 63
5.17 CardioPlus, Inc. Company Overview 67
5.17.1 CardioPlus, Inc. Pipeline Products & Ongoing Clinical Trials Overview 67
5.18 Carmat SAS Company Overview 68
5.18.1 Carmat SAS Pipeline Products & Ongoing Clinical Trials Overview 68
5.19 Charite – Universitatsmedizin Berlin Company Overview 72
5.19.1 Charite – Universitatsmedizin Berlin Pipeline Products & Ongoing Clinical Trials Overview 72
5.20 Cleveland Heart, Inc. Company Overview 73
5.20.1 Cleveland Heart, Inc. Pipeline Products & Ongoing Clinical Trials Overview 73
5.21 CorasMedical Company Overview 76
5.21.1 CorasMedical Pipeline Products & Ongoing Clinical Trials Overview 76
5.22 CorAssist Cardiovascular Ltd. Company Overview 77
5.22.1 CorAssist Cardiovascular Ltd. Pipeline Products & Ongoing Clinical Trials Overview 77
5.23 CorInnova, Inc. Company Overview 81
5.23.1 CorInnova, Inc. Pipeline Products & Ongoing Clinical Trials Overview 81
5.24 CorWave Company Overview 86
5.24.1 CorWave Pipeline Products & Ongoing Clinical Trials Overview 86
5.25 Drexel University Company Overview 87
5.25.1 Drexel University Pipeline Products & Ongoing Clinical Trials Overview 87
5.26 DUALIS MedTech GmbH Company Overview 88
5.26.1 DUALIS MedTech GmbH Pipeline Products & Ongoing Clinical Trials Overview 88
5.27 Ension, Inc. Company Overview 90
5.27.1 Ension, Inc. Pipeline Products & Ongoing Clinical Trials Overview 90
5.28 Evaheart, Inc. Company Overview 91
5.28.1 Evaheart, Inc. Pipeline Products & Ongoing Clinical Trials Overview 91
5.29 Everheart Systems, LLC Company Overview 95
5.29.1 Everheart Systems, LLC Pipeline Products & Ongoing Clinical Trials Overview 95
5.30 Foster-Miller, Inc. (Inactive) Company Overview 96
5.30.1 Foster-Miller, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 96
5.31 Fundacion para la Investigacion Biomedica del Hospital Gregorio Maranon Company Overview 97
5.31.1 Fundacion para la Investigacion Biomedica del Hospital Gregorio Maranon Pipeline Products & Ongoing Clinical Trials Overview 97
5.32 Gold Medical Technologies, Inc. Company Overview 98
5.32.1 Gold Medical Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 98
5.33 Harvard University Company Overview 99
5.33.1 Harvard University Pipeline Products & Ongoing Clinical Trials Overview 99
5.34 HeartWare International, Inc. Company Overview 100
5.34.1 HeartWare International, Inc. Pipeline Products & Ongoing Clinical Trials Overview 100
5.35 Jarvik Heart, Inc. Company Overview 122
5.35.1 Jarvik Heart, Inc. Pipeline Products & Ongoing Clinical Trials Overview 122
5.36 LaunchPoint Technologies, Inc. Company Overview 126
5.36.1 LaunchPoint Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 126
5.37 Leviticus Cardio Ltd. Company Overview 127
5.37.1 Leviticus Cardio Ltd. Pipeline Products & Ongoing Clinical Trials Overview 127
5.38 Levram Medical Systems Ltd Company Overview 129
5.38.1 Levram Medical Systems Ltd Pipeline Products & Ongoing Clinical Trials Overview 129
5.39 Lonestar Heart, Inc. Company Overview 130
5.39.1 Lonestar Heart, Inc. Pipeline Products & Ongoing Clinical Trials Overview 130
5.40 Mayo Clinic. Company Overview 135
5.40.1 Mayo Clinic. Pipeline Products & Ongoing Clinical Trials Overview 135
5.41 MicroMed Cardiovascular, Inc. Company Overview 137
5.41.1 MicroMed Cardiovascular, Inc. Pipeline Products & Ongoing Clinical Trials Overview 137
5.42 Microstim GmbH Company Overview 138
5.42.1 Microstim GmbH Pipeline Products & Ongoing Clinical Trials Overview 138
5.43 MyoCardioCare, Inc. Company Overview 139
5.43.1 MyoCardioCare, Inc. Pipeline Products & Ongoing Clinical Trials Overview 139
5.44 MyoPowers Medical Technologies SA Company Overview 142
5.44.1 MyoPowers Medical Technologies SA Pipeline Products & Ongoing Clinical Trials Overview 142
5.45 NeoCardial Technologies, LLC Company Overview 143
5.45.1 NeoCardial Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview 143
5.46 New Heart Company Overview 144
5.46.1 New Heart Pipeline Products & Ongoing Clinical Trials Overview 144
5.47 Nipro Corporation Company Overview 145
5.47.1 Nipro Corporation Pipeline Products & Ongoing Clinical Trials Overview 145
5.48 NuVascular Technologies Inc Company Overview 147
5.48.1 NuVascular Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 147
5.49 Orqis Medical Corporation Company Overview 148
5.49.1 Orqis Medical Corporation Pipeline Products & Ongoing Clinical Trials Overview 148
5.50 Penn State Milton S. Hershey Medical Center Company Overview 150
5.50.1 Penn State Milton S. Hershey Medical Center Pipeline Products & Ongoing Clinical Trials Overview 150
5.51 Perfusion Solutions Company Overview 152
5.51.1 Perfusion Solutions Pipeline Products & Ongoing Clinical Trials Overview 152
5.52 PlugMed Heart SAS Company Overview 153
5.52.1 PlugMed Heart SAS Pipeline Products & Ongoing Clinical Trials Overview 153
5.53 Procyrion Company Overview 154
5.53.1 Procyrion Pipeline Products & Ongoing Clinical Trials Overview 154
5.54 Purdue University Company Overview 155
5.54.1 Purdue University Pipeline Products & Ongoing Clinical Trials Overview 155
5.55 QRS Diagnostic, LLC Company Overview 157
5.55.1 QRS Diagnostic, LLC Pipeline Products & Ongoing Clinical Trials Overview 157
5.56 ReliantHeart, Inc. Company Overview 158
5.56.1 ReliantHeart, Inc. Pipeline Products & Ongoing Clinical Trials Overview 158
5.57 Saint Louis University Company Overview 161
5.57.1 Saint Louis University Pipeline Products & Ongoing Clinical Trials Overview 161
5.58 St. Jude Medical, Inc. Company Overview 163
5.58.1 St. Jude Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 163
5.59 Sunshine Heart Company, Pty. Ltd. Company Overview 176
5.59.1 Sunshine Heart Company, Pty. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 176
5.60 SynCardia Systems, Inc. Company Overview 182
5.60.1 SynCardia Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 182
5.61 Teleflex Incorporated Company Overview 194
5.61.1 Teleflex Incorporated Pipeline Products & Ongoing Clinical Trials Overview 194
5.62 Terumo Corporation Company Overview 196
5.62.1 Terumo Corporation Pipeline Products & Ongoing Clinical Trials Overview 196
5.63 The Artificial Heart Laboratory of Foundation for Cardiac Surgery Development Company Overview 198
5.63.1 The Artificial Heart Laboratory of Foundation for Cardiac Surgery Development Pipeline Products & Ongoing Clinical Trials Overview 198
5.64 The University of Tokyo Company Overview 199
5.64.1 The University of Tokyo Pipeline Products & Ongoing Clinical Trials Overview 199
5.65 U.S. Stem Cell, Inc. Company Overview 201
5.65.1 U.S. Stem Cell, Inc. Pipeline Products & Ongoing Clinical Trials Overview 201
5.66 University of Minnesota Company Overview 203
5.66.1 University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview 203
5.67 University of Zurich Company Overview 205
5.67.1 University of Zurich Pipeline Products & Ongoing Clinical Trials Overview 205
5.68 Vadovations, Inc. Company Overview 206
5.68.1 Vadovations, Inc. Pipeline Products & Ongoing Clinical Trials Overview 206
5.69 Vienna University of Technology Company Overview 207
5.69.1 Vienna University of Technology Pipeline Products & Ongoing Clinical Trials Overview 207
5.70 Windmill Cardiovascular Systems, Inc. Company Overview 208
5.70.1 Windmill Cardiovascular Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 208
6 Cardiac Assist Devices- Recent Developments 209
7 Appendix 320
7.1 Methodology 320
7.2 About GlobalData 322
7.3 Contact Us 323
7.4 Disclaimer 323
【レポート販売概要】
■ タイトル:世界の心臓補助装置開発動向:医療機器パイプライン分析2015■ 英文:Cardiac Assist Devices - Medical Devices Pipeline Assessment, 2015
■ 発行日:2016年1月5日
■ 調査会社:GlobalData
■ 商品コード:GDME0142EPD
■ 調査対象地域:グローバル
- 世界の紫外線LED市場2015The Global UV LED Industry 2015 Market Research Report is a professional and in-depth study on the current state of the UV LED industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The UV LED market analysis is provided for the international markets including development trends, competitive landscape analysi …
- 航空宇宙用コーティングの世界市場2016-2026Visiongain’s comprehensive new 181 page report reveals that the aerospace coatings market will achieve revenues of $584.5m in 2016. Are you involved in the aerospace coatings market or intend to be? If so, then you must read this report It’s vital that you keep your knowledge up to date. You need this report. Market scope: Aerospace coatings are supplied to the commercial, military, and general av …
- 世界の定置用燃料電池市場:Global Stationary Fuel CellsFuel cells have been promoted as the next technological leap in the area of power production and the reason for the excitement around this technology is primarily because of the fact that they carry the potential to replace the traditional combustion-based electric generating technologies in both mobile and stationary applications. In terms of the fuel that is used, they can operate on any hydroge …
- 構造発泡体の世界市場:ポリエチレン、ポリプロピレン、ポリスチレン、ポリウレタンStructural foams are defined as thermoplastic products, which have a foamed cellular core with a solid skin surrounding the core. It is generally developed through a form of injection molding, by using molten plastic/polymer mixed with a chemical blowing agent or inert gas. Other processes such as reaction injection molding (RIM), high pressure expansion, and co-injection are also used for manufac …
- クラウドストレージサービスの世界市場予測・分析2020-2024Global Cloud Storage Services Market: About this market Technavio’s cloud storage services market analysis considers sales from both large enterprises and SMEs end-users. Our study also finds the sales of cloud storage services in APAC, Europe, MEA, North America, and South America. In 2018, the large enterprise's segment had a significant market share, and this trend is expected to continue over …
- 航空機付随サービスの世界市場2017-2021:FFPマイル販売、機内販売・アラカルトサービス、手荷物料金、旅行小売りAbout Airline Ancillary ServicesAirlines continue to focus on boosting ancillary revenues through adopting advanced technologies and collaborations with global distribution system (GDS) providers. Some of the key sources of ancillary revenue comprise fees for ticket change, baggage, annual subscriptions to premium services, extra amenities, frequent flyer programs (FFPs), and onboard duty-free sal …
- マイクロ灌漑システムの世界市場2019-2023About this market The growing government support for installing micro irrigation system will lead the market to witness considerable growth in the forthcoming years. Government agencies across the globe are focusing on increasing the efficient use of water in the agriculture sector. This will further promote and encourage farmers to use micro irrigation technologies and systems for ensuring water …
- 米国の不眠症治療市場予測(~2021):非薬理学的療法別(認知行動療法、催眠療法)、処方せん睡眠薬別(ベンゾジアゼピン、非ベンゾジアゼピン(ザレプロン)、オレキシン遮断薬,)、一般用治療別(抗ヒスタミン剤、メラトニン、ワレリアナ根))The U.S. insomnia market is projected to reach USD 4.24 billion by 2021 from USD 3.38 billion in 2016, growing at a CAGR of 4.6% from 2016 to 2021. In 2016, the cognitive behavioural therapy for insomnia (CBTI) segment is expected to account for the largest share of the market. The other alternative therapies include exercise/yoga, acupuncture, biofeedback, bright light therapy, music therapy, and …
- 医療料金アウトソーシングの世界市場2015-2019About Global Medical Billing Outsourcing Globally, healthcare spending is expected to increase, which will put additional pressure on healthcare delivery systems, governments, and insurers. The major reasons for increased spending in developed countries are an aging population and lower fertility rate; in emerging countries, it is the lack of infrastructure, increase in chronic diseases, and inequ …
- [Updated] 世界のeClinical (臨床試験電子化)ソリューション市場動向(~2018)The global eClinical solutions market is estimated to grow at a CAGR of 13.5% and is expected to reach ~$5 billion by 2018. Compared to matured markets, the Asia-Pacific region is expected to grow at the highest CAGR of 19.5%. The growth of the eClinical solutions market is primarily triggered by factors such as, growth in the number of clinical trials, increasing government pressure to reduce the …
- 世界の先進CO2センサー市場2015The Global Advanced CO2 Sensors Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Advanced CO2 Sensors industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Advanced CO2 Sensors market analysis is provided for the international markets including develop …
- PP不織布の世界市場:スパンボンド不織布、ステープル不織布、メルトダウン不織布、複合不織布About PP Non-woven Fabric Non-woven fabrics are sheets or webbed structures that are bonded together by chemical, thermal, or mechanical processes. They are not formed by knitting or weaving. PP non-woven fabrics can be divided into four segments based on type: Spunbonded, Staple, Meltdown, and Composite. They are used for various applications such as in the Hygiene, Construction, Geotextile, Filt …
- 自動車用カムレス型のエンジンの世界市場2017-2021About Automotive Camless Engine An automotive camless engine is defined as an engine configuration wherein the poppet valves are operated using pneumatic, electrohydraulic, or electromagnetic actuator systems instead of conventional cams. The intake or exhaust valves are operated using the camless arrangement of the camshaft, which incorporates the use of springs or other means. This type of engin …
- 高速鉄道(HSR)向け複合材の世界市場:ガラス複合材、炭素複合材About Composites for HSR HSR is a railway transportation system that runs at speeds of more than 150 mph and is currently considered one of the fastest, most environment-friendly, and safest modes of transport across the globe. HSR systems, since their advent, have been an integral part of the transportation sector in developed countries in Europe and APAC. These systems provide the advantages of …
- Alzheimer’s Disease Therapeutics Market to 2019 – Early Stage Innovation Points to Disease Modifying Therapies and Market TransformationAlzheimer’s Disease Therapeutics Market to 2019 - Early Stage Innovation Points to Disease Modifying Therapies and Market Transformation Summary GBI Research has released its pharmaceuticals report, "Alzheimer’s Disease Therapeutics Market to 2019 - Early Stage Innovation Points to Disease Modifying Therapies and Market Transformation". The Alzheimer’s Disease (AD) market is characterized by a lac …